Don’t use these drugs, FDA warns
THE Food and Drug Administration (FDA) has warned the public against the use of 22 unregistered medicines sold in the market that could pose health risks to consumers.
Jeffrey Gamboa, food and drug registration officer of FDA-Region I, said the safety and efficacy of these unregistered drugs could not be assured because these were not subjected to government’s evaluation and registration.
The unregistered drugs being sold in the market are Bisacodyl (Delax) 5 mg tablet; Conjugated Estrogens USP (Conjugase-0.625) 0.625 mg tablet; Bicalutamide 50 mg tablet; Isosorbide dinitrate (Hartsorb Sublingual) 5 mg tablet; Flunarazine (Sobelin) 5 mg capsule; Loratadine (Clatidyne) 10 mg tablet; Diclofenac Sodium + Misoprostol (Arthrotec 50) 50 mg/ 200 mcg tablet; Cetirizine.2HCl (Cetrizin) 10 mg tablet; Clindamycin (Clindacap-300) 300 mg tablet; and Simvastatin (Zimmex 20) 20 mg tablet;
Rosiglitazone maleate (Avandia) 4 mg Tablet; Gentamicin sulfate (Gentaderm) 0.1 g/ 100 g Cream; Nystatin (Tystatin) Oral Suspension; Dexamethasone Sodium Phosphate + Neomycin Sulfate (Archidex) Eye-Ear Drops; Omeprazole (Omeprazole GPO) 20 mg Capsule; Roxithromycin (Roxthrin) 150mg Tablet; Lansoprazole 30 mg Delayed-Release Capsule; Ketoconazole (Ninazol) 200 mg Tablet; Paracetamol (SaRa) 500 mg Tablet; Amoxicillin + Clavulanate Potassium 400 mg/ 57 mg per 5 mL Oral Suspension; Cefuroxime Axetil (Cefuroxime) 250 mg/ 5 mL Oral Suspension; and Cefdinir 250 mg/ 5 mL Oral Suspension.
“FDA will confiscate these should they be found in the market,” Gamboa said. (PIA- Pangasinan)
Share your Comments or Reactions
Powered by Facebook Comments
